The envelope glycoproteins of two distinct strains of respiratory syncytial virus (RSV) (Long and 18537 strains) were purified by affinity chromatography and characterized by immunological methods. The fusion (F) proteins from the two strains were similar in molecular weight by gel electrophoresis and were very closely related immunologically. Rabbit antisera to either F protein reacted with near equivalent titres with the heterologous F protein by Western blot, enzyme-linked immunoassay (EIA), neutralization and fusion inhibition assays. In contrast to the similarity of the F proteins, the attachment proteins (G) differed significantly. The 18537 G protein had a molecular weight of 78K compared to 84K for the Long G protein. Rabbit antisera to the G proteins clearly reacted preferentially with the homologous protein, although some cross-reactivity was noted by Western blot and EIA. Anti-G serum neutralized the homotogous strain of RSV in the presence or absence of complement to much higher titre than the heterologous virus strain. The implications for vaccine development are discussed.
INTRODUCTION
Respiratory syncytial virus (RSV) is the leading cause of severe lower respiratory infections in infants (Parrott et al., 1973) . Epidemiological studies indicate that half of all children become infected in the first year of life and virtually all have been infected by 2 years of age (Henderson et al., 1979) . The most severe infections occur between 2 and 6 months and reinfections, although less severe, are common throughout childhood and adulthood and occur despite the presence of antibody to the virus (Parrott et al., 1973; Henderson et al., 1979; Hall et al., 1976) . Possible explanations for this incomplete immunity include strain variation among RSV isolates (Hendry et al., 1986) . Whether clinically relevant strain variation occurs among human RSV isolates is not completely clear.
An early study using human convalescent sera in neutralization and complement fixation tests demonstrated only minor strain differences between two prototype strains of RSV, the Long and 18537 isolates (Coates et al., 1963) . However, the same investigators were able to demonstrate significant differential neutralization of these two strains using hyperimmune ferret antisera raised to each virus strain (Coates et al., 1963 (Coates et al., , 1966 . In later studies, other investigators were unable to demonstrate significant clinical differences in disease despite the presence of strain variation as determined by differential neutralization (Hierholzer & Hirsh, 1979) , and noted that cotton rats immunized with one strain were protected when challenged with a different strain (Prince et al., 1985) . Based upon these studies it was concluded that clinically relevant strain variation probably did not exist. Recent information regarding the structure and function of the RSV proteins may offer new insight into the analysis of these previous findings.
The RSV genome codes for at least 10 proteins, including 90K and 70K envelope glycoproteins (Huang et al., 1985) . The 90K glycoprotein probably functions as the attachment protein (G), while the 70K protein is a typical paramyxovirus fusion protein (F) which promotes 0000-7666 © 1987 SGM viral entry into cells and cell to cell spread of virus by fusion of infected cells to adjacent uninfected cells (Walsh et al., 1984 (Walsh et al., , 1985 . Antibody directed to either protein neutralizes the virus, while only antibody to the F protein inhibits fusion. Convalescent antiserum to one strain of RSV might neutralize other strains by attachment to either the G or F proteins, or both. Therefore, strain variation among RSV isolates could be present on either or both envelope glycoproteins.
The availability of monoclonal antibodies (MAbs) to analyse antigenic relatedness of the F and G proteins among strains allowed Anderson et al. (1985) to define at least two distinct strains of RSV, represented by the prototype Long and 18537 isolates of the virus. Also using MAbs but using different techniques, Mufson et al. (1985) defined two subtypes among clinical isolates of RSV. The major antigenic difference between strains resided on the G protein, where it was noted that five of six MAbs defined epitopes that differed between the two RSV subtypes (Mufson et al., 1985) . Recently, strain variation has also been demonstrated for the 32K phosphoprotein (Gimenez et al., 1986) . Although these results indicate that strain variation primarily exists on the G protein, MAbs may be so specific and narrow in their interaction with the G protein that clinically unimportant differences may be noted. Monospecific polyclonal antiserum to G should reflect the natural immune response to infection and better delineate clinically relevant differences among RSV strains.
In an attempt to investigate further the antigenic relatedness of the two proposed prototype strains of RSV, we purified the G and F proteins of the 18537 strain and the Long strain of RSV and characterized them with monoclonal and monospecific polyclonal antibodies.
METHODS

Virus and cells.
HEp-2 cells were maintained in MEM supplemented with 1 mM-glutamine and 5% foetal calf sera (FCS). The Long strain of RSV, grown in 5% FCS, and the 18537 strain of RSV (obtained from Kenneth McIntosh, Harvard Medical School, Boston, Mass., U.S.A.), grown in 3% rabbit serum, were kept frozen at -70 °C until use. Purification of G and Fproteins. The G and F proteins of Long strain and 18537 strain were purified by affinity chromatography using the same MAbs as previously described (Walsh et al., 1984 (Walsh et al., , 1985 . Prior to purification of 18537 G and F, the ability of the F-and G-specific MAbs to bind to 18537 G and F proteins was demonstrated by indirect immunofluorescence on infected cells. For purification, RSV-infected HEp-2 cells were lysed with nondenaturing detergent buffer when the cytopathic effect was extensive (approx. 48 to 72 h for Long strain and 72 to 96 h for 18537 strain). The lysate was clarified and passed through an affinity column containing a MAb to either F or G. The column was extensively washed with phosphate-buffered saline (PBS), 0-1% Triton X-100, and then eluted with 0-1 M-glycine-HC1, 0.1 ~ Triton X-100 pH 2-5.
Antibodies. Antibodies used in this study include 13 previously described MAbs to the F protein , monospecific rabbit polyclonal antibodies to Long F and G proteins (Walsh et al., 1984 (Walsh et al., , 1985 and monospecific rabbit sera to 18537 G and F proteins. The latter were produced by immunizing six-week-old New Zealand white rabbits with 20 p.g of 18537 G or 10 ~tg of 18537 F protein in complete Freund's adjuvant, followed by a similar dose in incomplete Freund's adjuvant 4 weeks later. All injections were given subcutaneously. Animals were bled starting 1 week after the booster dose and the sera stored at -70 °C until use.
Neutralization and inhibition of fusion assays (IOFA).
A microneutralization assay was performed with and without rabbit complement using a modification of a published enzyme immunoassay . Briefly, dilutions of sera were incubated with 100 p.f.u, of either 18537 or Long strain RSV for 45 min in 96-well microtitre plates, with or without fresh rabbit complement. Then, 1.5 x 104 HEp-2 cells previously suspended by EDTA treatment were placed in each well, and the plates incubated for 3 days. The cells were fixed as described and developed using MAbs to the nucleocapsid protein and the phosphoprotein followed by horseradish peroxidase-labelled rabbit anti-mouse IgG. The neutralization titre was defined as a 50% reduction in colour development, compared to preimmune sera. IOFA of Long and 18537 strain were performed with heatinactivated (56°C for 30 min) sera using previously described methods (Walsh et al., 1984 (Walsh et al., , 1985 .
Enzyme-linked immunoassay (EIA).
The ability of MAbs directed to F to bind to the purified F proteins was determined in a solid phase EIA as previously reported . Twenty-five ng of F (Long or 18537) was coated to plastic microelisa wells (Dynatech Laboratories, Alexandria, Va., U.S.A. ; Immulou-2) overnight at 4 °C. The wells were blocked using PBS with 5 % bovine serum albumin (BSA) for 30 rain, washed with PBS and then incubated with dilutions of MAb in PBS with BSA and 0-1% Tween-20. Bound MAb was detected with an alkaline phosphatase-labelled goat anti-mouse IgG and substrate. Optical density at 410 nm was read with a Dynatech automated ELISA reader. A similar EIA was used to quantify binding by the various rabbit sera to G and F proteins except that alkaline phosphatase-labelled goat anti-rabbit IgG was used prior to the addition of substrate. SDS-PAGE and Western blotting. SDS-PAGE and Western blotting were performed as previously described with minor modifications . For Western blotting, the purified F and G of 18537 and Long strain were separated by SDS-PAGE and the proteins transferred to nitrocellulose paper. After transfer the nitrocellulose paper was washed with PBS with 5~ Carnation instant milk (BLOTTO) for 30 min at room temperature. The paper was cut into strips and probed with 2 ml of a 1:200 dilution of rabbit antiserum in BLOTTO, followed by horseradish peroxidase-labeUed goat anti-rabbit IgG and substrate.
RESULTS
G protein
The 18537 G protein was readily recovered from affinity columns in quantities equivalent to recovery of Long strain G protein using identical procedures. On S D S -P A G E the 18537 G migrated as a diffuse band of 78K similar to the described characteristics of the Long G protein but of somewhat lower molecular weight (Fig. 1) . Antisera from two rabbits immunized with 18537 G (designated 14-015 and t4-016) and a previously described rabbit antiserum to Long G (14-04) were then used to analyse the antigenic relatedness of 18537 G by Western blot, EIA and neutralization tests.
By Western blot analysis, 14-016 (anti-18537 G) reacted strongly with purified 18537 G but only weakly with Long G (heterologous protein), whereas 14-015 (anti-18537 G) reacted only with 18537 G (Fig. 2) . Conversely, 14-04 (anti-Long G) reacted strongly with Long G and weakly with 18537 G. This heterologous reaction is poorly reproduced in Fig. 2 . The 'ladder' precursor proteins of G are evident in the Long G preparation (Fig. 2, lane 1) but not in the 18537 G preparation. This difference is probably not significant, since our experience with purification o f Long G has shown that recovery of the 'ladder' proteins is variable. The MAb used to purify G reacts with the 'ladder' proteins by Western blot (data not shown), and the degree of purity of G preparations may reflect differing avidities of the MAb for the 'ladder' proteins and complete G and their relative amounts in the starting cell lysate. present at 1:25 dilution; -, no fusion-inhibiting activity at 1:25 dilution.
Using an E I A , similar differential reactivity of these antisera was noted (Table 1 ). The 14-015 reacted to high titre with 18537 G (1:25 600) and weakly with Long G (1:50). The 14-016 also reacted primarily with the homologous G proteins, as did 14-04.
The ability of the antisera to neutralize the Long and 18537 strains of R S V was then tested. In the absence of complement, 14-04 (anti-Long G) neutralized Long R S V strongly (titre 2560) but only weakly neutralized 18537 R S V (titre 20); 14-015 (anti-18537 G) strongly neutralized 18537 RSV (titre 1280) and weakly neutralized Long RSV (titre 20); 14-016 (anti-18537 G) neutralized 5) and 18537 (lanes 6 to 10) F proteins. One hundred ng of purified F was separated by SDS PAGE (11~ acrylamide gels) under non-reducing conditions without heating of the sample. Under these conditions F migrates as a 140K dimer in a doublet form. After transfer, nitrocellulose paper was cut into strips and probed with hyperimmune rabbit serum as described in Methods. Sera were as follows: 14-06-0 (control, lanes 1 and 6), 14-06-6 (anti-Long F, lanes 2 and 7), 14-07 (anti-Long F, lanes 3 and 8), 14-019 (anti-18537 F, lanes 4 and 9) and 14-020 (anti-18537 F, lanes 5 and 10).
the 18537 RSV strain weakly (titre 40) and did not neutralize the Long strain. When complement was added to the neutralization assay, neutralization of the heterologous virus increased approximately fourfold although homologous neutralizing titres were still considerably greater (Table 1) . The weak neutralizing capacity of antiserum 14-016 probably reflects the relatively low titre of this serum as determined by EIA. The antigenic relatedness of the G proteins was calculated according to the Archetti Horsfall formula (Archetti & Horsfall, 1950) . Values based upon differential EIA and neutralizing ability ranged from 0.12 to 3.1 ~ relatedness for the G proteins.
F protein
Although 18537 F protein was eluted from the affinity column, the amount recovered was small (approx. 150 gg/procedure) when compared to purification of Long strain F protein (approx. 750 ~g/procedure). The possible reasons for this poor recovery, which include failure to bind or elute from the column or decreased cellular production of F, have not been investigated. The F proteins from 18537 and Long had similar migration patterns on P A G E with a molecular weight of 70K (when heated to 100 °C), and also migrated as a 140K dimer in a doublet form, when not heated (data not shown). Two rabbit antisera raised against 18537 F (14-019 and 14-020) were then compared to two previously described antisera to Long F (14-06 and 14-07). All four antisera reacted with Long and 18537 proteins by Western blot analysis when the F protein migrated as a 140K dimer (Fig. 3) . When the two F proteins were boiled prior to S D S -P A G E , the anti-Long F sera (14-07 and 14-06) reacted with the 70K form of both Long and 18537 F proteins, while the anti-18537 sera (14-019 and 14-020) did not react with either 70K protein (data not shown). . ~ Neut, NeutraIizing activity; FI, fusion-inhibiting activity.
In the EIA, antisera to Long F (14-06 and 14-07) reacted nearly equally with Long and 18537 F. The slight difference in activity may be due to imprecision in using exactly the same amount of F protein in the two assays. All of the antisera to the F proteins had a twofold to fourfold higher titre to the 18537 F protein than to Long F. Each antiserum tested was capable of neutralizing either RSV strain in the absence of complement to nearly equivalent titres, and also inhibited fusion of both strains. The calculated relatedness of the two proteins ranged from 70 to
100%.
We then studied the comparative binding of a panel of 13 MAbs which had previously been used to describe five epitopes on the Long F protein. These epitopes include three neutralizing, fusion-inhibiting epitopes, one neutralizing non-fusion-inhibiting epitope and one nonneutralizing epitope . Three of five epitopes present on the Long strain F protein were also present on the 18537 F protein ( Table 2 ). The three neutralizing fusioninhibiting epitopes were common to both F proteins, while the non-fusion-inhibiting neutralizing epitope and the non-neutralizing epitope were absent from 18537 F protein. This differential reactivity was confirmed by indirect immunofluorescence on acetone-fixed infected HEp-2 cells.
DISCUSSION
The inability to develop a solid protective immune response following primary RSV infections is unexplained. Included among various possible reasons for this incomplete immunity is strain variation among circulating RSV isolates. In the study reported here we have characterized the purified G and F proteins from two strains of RSV which others have suggested as prototype strains based upon MAb reactivity. By SDS-PAGE the molecular weights of the F proteins were similar, contrary to the minor 1K to 2K size difference in the F 1 fragments reported by Norrby et al. (1986) . Our failure to identify a size difference may be due to the use of a different cell line. The F proteins of both strains were antigenically similar. Hyperimmune rabbit antisera to the F proteins reacted strongly with the heterologous F protein by Western blot analysis and when quantified by EIA, significant cross-reactivity was noted. In addition, we found that the 18537 F protein shares three of five MAb-defined epitopes with the Long F protein. The common epitopes are fusion-inhibiting, neutralizing sites and are likely to be important functional sites of the F protein. Consistent with these findings, crossneutralization and fusion-inhibiting activities were similar for each serum. Based upon these data, the F proteins of the 18537 and Long strains are very similar antigenically and antiserum to either F protein has important biological activity towards both strains of RSV.
A potential limitation of these results is that the purification techniques, which include acid elution at pH 2.5, may denature the F proteins, thus obscuring significant antigenic differences. It has been demonstrated that F protein cleavage products differ between subtype A and B strains when analysed by radioimmunoprecipitation (Norrby et al., 1986) . However, there was consistent correlation between the presence of MAb-defined epitopes on F using either affinitypurified F or by indirect immunofluorescence with infected HEp-2 cells.
Conversely, the 18537 G protein differed substantially from the Long G protein. By SDS-PAGE, 18537 G has a lower apparent molecular weight than Long G, perhaps reflecting differences in glycosylation of G, a finding consistent with other reports (Norrby et al., 1986) . Monospecific rabbit sera clearly reacted preferentially with the homologous G protein by Western blot and EIA. More importantly, the neutralizing capacity of the sera was significantly greater for the homologous virus strain. Neutralization of the heterologous strain did increase slightly when complement was added to the virus-antibody mixture. The degree of neutralization was approximately proportional to the EIA reactivity, although one of the sera (14-016) did not neutralize Long strain with complement despite weak cross-reactivity by blot and EIA.
This information offers some insight into the equivocal findings of the earlier work on strain variation using convalescent antisera. Following infection with one strain of RSV, children develop IgG antibody directed to both the F and G proteins (Murphy et al., 1986) . Neutralization of the homologous virus by convalescent sera would occur by binding to both the F and G proteins. However, based upon the data reported here heterologous neutralization would primarily occur by binding to the common F protein, with a small contribution by crossreactivity to the G protein. However, as discussed above, it is possible that the methods employed in this study may obscure differences between the F proteins, thus underestimating the role of the F proteins in strain variation.
The results of this study have direct relevance to the development of an RSV vaccine. Immunization of experimental animals with purified Long F or G proteins results in complete pulmonary protection from challenge with Long strain RSV (Walsh et al., 1987) . These data suggest that immunization with purified Long F protein should also protect animals from infection with strain 18537. Since some immunological cross-reactivity, including complementenhanced neutralization, occurs between G proteins, immunization with Long G might also offer a lesser degree of heterologous protection. These studies are now in progress.
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